Ching-Yen Lin
Impact in
- Pharmacology top 10%
- Piperaceae Chemical and Biological Studies
-
- Tuberculosis Research and Epidemiology
Papers in
-
- Gut microbiota and health 5
-
- Lipid metabolism and disorders 4
- Co-authors
- Pei‐Yi Chen (6 shared papers)Jui-Hung Yen (6 shared papers)Ming‐Jiuan Wu (5 shared papers)Ying‐Ray Lee (8 shared papers)Kelly S. Swanson (6 shared papers)J. Suo (1 shared paper)Kao-Jean Huang (4 shared papers)Yun-Ping Lim (3 shared papers)
- Journals
- International Journal of Molecular Sciences (5 papers)Journal of Animal Science (2 papers)Current Developments in Nutrition (2 papers)Frontiers in Pharmacology (1 paper)Biomedicines (1 paper)
- Partner nations
- TaiwanUnited StatesUnited Arab Emirates
In The Last Decade
Ching-Yen Lin
24 papers receiving 536 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 43
- Infectious Diseases 78
- Biochemistry 23
- Cancer Research 47
- Toxicology 10
Countries citing papers authored by Ching-Yen Lin
This map shows the geographic impact of Ching-Yen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Yen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Yen Lin more than expected).
Fields of papers citing papers by Ching-Yen Lin
This network shows the impact of papers produced by Ching-Yen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Yen Lin. The network helps show where Ching-Yen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching-Yen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. | 2003 | 76 |
| 2 | 2021 | 51 | |
| 3 | 2020 | 38 | |
| 4 | 2022 | 38 | |
| 5 | 2014 | 37 | |
| 6 | 2016 | 36 | |
| 7 | 2018 | 36 | |
| 8 | 2020 | 34 | |
| 9 | 2013 | 30 | |
| 10 | 2016 | 30 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 21 | |
| 13 | 2018 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2018 | 13 | |
| 16 | 2018 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2018 | 10 | |
| 19 | 2013 | 8 | |
| 20 | 2023 | 6 |
About Ching-Yen Lin
Ching-Yen Lin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Pathology and Forensic Medicine and Nutrition and Dietetics, having authored 25 papers that have together received 557 indexed citations. Recurring topics across this work include Gut microbiota and health (5 papers), Lipid metabolism and disorders (4 papers), Antimicrobial Peptides and Activities (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Mechanisms and Therapy (2 papers), Diet and metabolism studies (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Pharmacology (43 citations), Infectious Diseases (78 citations), Biochemistry (23 citations), Cancer Research (47 citations) and Toxicology (10 citations). Ching-Yen Lin has collaborated with scholars based in Taiwan, United States and United Arab Emirates. Frequent co-authors include Pei‐Yi Chen, Jui-Hung Yen, Ming‐Jiuan Wu, Ying‐Ray Lee, Kelly S. Swanson, J. Suo, Kao-Jean Huang, Yun-Ping Lim, Je-Wen Liou and Ching‐Liang Chu. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Animal Science, Current Developments in Nutrition, Frontiers in Pharmacology and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.